THYROCARE TECHNOLOGIES Financial Statement Analysis
|
||
The Revenues of THYROCARE TECHNOLOGIES have increased by 8.58% YoY .
The Earnings Per Share (EPS) of THYROCARE TECHNOLOGIES has increased by 27.57 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
THYROCARE TECHNOLOGIES Last 5 Annual Financial Results
[BOM: 539871|NSE : THYROCARE]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Operating Income | ₹572 Cr | ₹527 Cr | ₹589 Cr | ₹495 Cr | ₹434 Cr |
Expenses | ₹433 Cr | ₹404 Cr | ₹353 Cr | ₹323 Cr | ₹261 Cr |
Operating Profit (Excl OI) | ₹139 Cr | ₹123 Cr | ₹236 Cr | ₹171 Cr | ₹174 Cr |
Other Income | ₹9.37 Cr | ₹8.42 Cr | ₹29 Cr | ₹12 Cr | ₹6.67 Cr |
Interest | ₹5.53 Cr | ₹4.83 Cr | ₹3.21 Cr | ₹0.87 Cr | ₹1.85 Cr |
Depreciation | ₹47 Cr | ₹39 Cr | ₹34 Cr | ₹30 Cr | ₹32 Cr |
Profit Before Tax | ₹96 Cr | ₹89 Cr | ₹228 Cr | ₹152 Cr | ₹140 Cr |
Profit After Tax | ₹69 Cr | ₹64 Cr | ₹176 Cr | ₹113 Cr | ₹88 Cr |
Consolidated Net Profit | ₹71 Cr | ₹66 Cr | ₹176 Cr | ₹112 Cr | ₹89 Cr |
Earnings Per Share (Rs) | ₹17.12 | ₹13.42 | ₹12.47 | ₹33.28 | ₹21.14 |
PAT Margin (%) | 13.20 | 12.15 | 12.22 | 29.91 | 22.88 |
ROE(%) | 17.04 | 13.21 | 12.23 | 37.18 | 28.75 |
ROCE(%) | 27.25 | 18.75 | 17.61 | 48.42 | 38.51 |
Total Debt/Equity(x) | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 6,951.5 Cr |
Revenue (TTM) | : | ₹ 723.5 Cr |
Net Profit(TTM) | : | ₹ 106.1 Cr |
EPS (TTM) | : | ₹ 20.0 |
P/E (TTM) | : | 65.5 |
Industry Peers & Returns | 1W | 1M | 1Y |
THYROCARE TECHNOLOGIES | 10.2% | 30.9% | 73.6% |
MAX HEALTHCARE INSTITUTE | 5% | 1.1% | 33.7% |
APOLLO HOSPITALS ENTERPRISE | 3% | 5.2% | 14.7% |
FORTIS HEALTHCARE | 5.4% | 6.9% | 75.8% |
GLOBAL HEALTH | 1.8% | 16.9% | 10% |
NARAYANA HRUDAYALAYA | 3.8% | -3.8% | 57.9% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 2.2% | 12.8% | 86% |
DR LAL PATHLABS | 3.8% | 11.7% | 2% |
ASTER DM HEALTHCARE | -1% | -2.3% | 84.9% |
THYROCARE TECHNOLOGIES Revenues
[BOM: 539871|NSE : THYROCARE]
Y-o-Y | 8.58 % |
5 Yr CAGR | 7.12 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹572 Cr | 8.58 | |
Mar2024 | ₹527 Cr | -10.56 | |
Mar2023 | ₹589 Cr | 19.05 | |
Mar2022 | ₹495 Cr | 13.90 | |
Mar2021 | ₹434 Cr | - |
THYROCARE TECHNOLOGIES Operating Profit
[BOM: 539871|NSE : THYROCARE]
Y-o-Y | 13.25 % |
5 Yr CAGR | -5.44 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹139 Cr | 13.25 | |
Mar2024 | ₹123 Cr | -48.02 | |
Mar2023 | ₹236 Cr | 37.64 | |
Mar2022 | ₹171 Cr | -1.33 | |
Mar2021 | ₹174 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 4.25 % |
5 Yr CAGR | -11.73 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 24.26% | 4.25 | |
Mar2024 | 23.27% | -41.87 | |
Mar2023 | 40.03% | 15.63 | |
Mar2022 | 34.62% | -13.39 | |
Mar2021 | 39.97% | - |
THYROCARE TECHNOLOGIES Profit After Tax
[BOM: 539871|NSE : THYROCARE]
Y-o-Y | 7.62 % |
5 Yr CAGR | -5.35 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹71 Cr | 7.62 | |
Mar2024 | ₹66 Cr | -62.50 | |
Mar2023 | ₹176 Cr | 57.53 | |
Mar2022 | ₹112 Cr | 26.25 | |
Mar2021 | ₹89 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 8.64 % |
5 Yr CAGR | -12.85 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 13.2 % | 8.64 | |
Mar2024 | 12.15 % | -0.57 | |
Mar2023 | 12.22 % | -59.14 | |
Mar2022 | 29.91 % | 30.73 | |
Mar2021 | 22.88 % | - |
THYROCARE TECHNOLOGIES Earnings Per Share (EPS)
[BOM: 539871|NSE : THYROCARE]
Y-o-Y | 27.57 % |
5 Yr CAGR | -5.14 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹17 | 27.57 | |
Mar2024 | ₹13 | 7.62 | |
Mar2023 | ₹12 | -62.53 | |
Mar2022 | ₹33 | 57.43 | |
Mar2021 | ₹21 | - |
THYROCARE TECHNOLOGIES Return on Capital Employed (ROCE)
[BOM: 539871|NSE : THYROCARE]
Y-o-Y | 45.33 % |
5 Yr CAGR | -8.28 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 27.25% | 45.33 | |
Mar2024 | 18.75% | 6.47 | |
Mar2023 | 17.61% | -63.63 | |
Mar2022 | 48.42% | 25.73 | |
Mar2021 | 38.51% | - |
THYROCARE TECHNOLOGIES Share Price vs Sensex
Current Share Price | : | ₹1,311.6 |
Current MarketCap | : | ₹ 6,951.5 Cr |
Updated EOD on | : | Jul 25,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THYROCARE TECHNOLOGIES | 10.2% |
30.9% |
73.6% |
SENSEX | -0.4% |
-1.6% |
1.3% |
THYROCARE TECHNOLOGIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE HEALTHCARE | 0.5% | 4% | 17% |
BSE SMALLCAP | -2.5% | 0% | 2.1% |
You may also like the below Video Courses
FAQ about THYROCARE TECHNOLOGIES Financials
How the annual revenues of THYROCARE TECHNOLOGIES have changed ?
The Revenues of THYROCARE TECHNOLOGIES have increased by 8.58% YoY .
How the Earnings per Share (EPS) of THYROCARE TECHNOLOGIES have changed?
The Earnings Per Share (EPS) of THYROCARE TECHNOLOGIES has increased by 27.57 % YoY .
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs